SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-025921
Filing Date
2024-02-07
Accepted
2024-02-07 07:36:05
Documents
17
Period of Report
2024-02-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d695469d8k.htm   iXBRL 8-K 29248
2 EX-1.1 d695469dex11.htm EX-1.1 200534
3 EX-5.1 d695469dex51.htm EX-5.1 5666
4 EX-99.1 d695469dex991.htm EX-99.1 6644
  Complete submission text file 0001193125-24-025921.txt   429274

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA pepg-20240206.xsd EX-101.SCH 2835
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE pepg-20240206_lab.xml EX-101.LAB 18737
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pepg-20240206_pre.xml EX-101.PRE 11697
18 EXTRACTED XBRL INSTANCE DOCUMENT d695469d8k_htm.xml XML 3753
Mailing Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210
Business Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210 703-456-8000
PepGen Inc. (Filer) CIK: 0001835597 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41374 | Film No.: 24602172
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)